03:14 AM EDT, 05/21/2025 (MT Newswires) -- William Guyer, Chief Development Officer, on May 16, 2025, sold 32,262 shares in Corcept Therapeutics ( CORT ) for $2,393,014. Following the Form 4 filing with the SEC, Guyer has control over a total of 5,487 common shares of the company, with 5,487 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1088856/000095017025075484/xslF345X05/ownership.xml